Monitoring the impact of human papillomavirus vaccines on high-grade pre-invasive cervical lesions: Designing a framework of linked immunization information system and cancer registry data in Michigan

Vaccine

Volumn 33, Issue 11, 2014, Pages 1400-1405

  Potter, Rachel C ^a   Flagg, Elaine W ^b   Datta, S Deblina ^b   Saraiya, Mona ^c   Copeland, Glenn ^a  

^a MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Cancer registry; Cervical cancer; HPV vaccine; Human papillomavirus (HPV); Immunization information system (IIS)

Indexed keywords

WART VIRUS VACCINE;

BIRTH CERTIFICATE; CARCINOMA IN SITU; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMAN; INCIDENCE; INFORMATION SYSTEM; MEDICAL RECORD; REGISTER; TIME; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VACCINATION;

BIRTH CERTIFICATES; CARCINOMA IN SITU; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; INCIDENCE; INFORMATION SYSTEMS; MEDICAL RECORD LINKAGE; MICHIGAN; PAPILLOMAVIRUS VACCINES; REGISTRIES; TIME FACTORS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 84952717748     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.12.063     Document Type: Article

References (28)

1. Brotherton J.M., Kaldor J.M., Garland S.M. Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy. Sex Health 2010, 7(Sep (3)):310-319.
2. Fairley C.K., Donovan B. What can surveillance of genital warts tell us?. Sex Health 2010, 7(Sep (3)):325-327.
3. Markowitz L.E., Hariri S., Unger E.R., Saraiya M., Datta S.D., Dunne E.F. Post-licensure monitoring of HPV vaccine in the United States. Vaccine 2010, 28(Jul (30)):4731-4737.
4. Schuchat A., Bell B.P. Monitoring the impact of vaccines postlicensure: new challenges, new opportunities. Expert Rev Vaccines 2008, 7(May (4)):437-456.
5. Wong C.A., Saraiya M., Hariri S., Eckert L., Howlett R.I., Markowitz L.E., et al. Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries. Vaccine 2011, 29(Jan (5)):878-885.
6. Egelkrout E.M.G.D. Sexually transmitted diseases 2008, McGraw Hill Medical, New York City, NY. 4th ed.
7. Pagliusi S.R., Teresa Aguado M. Efficacy and other milestones for human papillomavirus vaccine introduction. Vaccine 2004, 23(Dec (5)):569-578.
8. Brotherton J.M., Fridman M., May C.L., Chappell G., Saville A.M., Gertig D.M. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011, 377(Jun (9783)):2085-2092.
9. National Cancer Institute Accelerating HPV vaccine uptake: urgency for action to prevent cancer. A report to the President of the United States from the President's cancer panel 2014, National Cancer Institute, Bethesda, MD.
10. Centers for Disease Control and Prevention About immunization information systems 2012, Centers for Disease Control and Prevention, Available from: http://www.cdc.gov/vaccines/programs/iis/about.html〉 (5/15/2012 [cited 2012 11/27/2012]).
11. Copeland G., Datta S.D., Spivak G., Garvin A.D., Cote M.L. Total burden and incidence of in situ and invasive cervical carcinoma in Michigan, 1985-2003. Cancer 2008, 113(Nov (10 Suppl)):2946-2954.
12. Harmon M.L., Cooper K. Cervical Neoplasia. Gynecologic Pathology 2009, Churchill Livingstone Elsevier, Philadelphia. M.R. Nucci, E. Oliva (Eds.).
13. Centers for Disease Control and Prevention. Registry plus link plus. 10/27/2009 [cited 11/27/2012]; Available from: http://www.cdc.gov/cancer/npcr/tools/registryplus/lp.htm
14. LexisNexis Accurint. [cited 04/23/2013]; Available from: www.accurint.com
15. Rana M.M., Huhtala H., Apter D., Eriksson T., Luostarinen T., Natunen K., et al. Understanding long-term protection of human papillomavirus vaccination against cervical carcinoma: cancer registry-based follow-up. Int J Cancer 2013, 132(12):2833-2838.
16. National HPV Vaccination Program Register About the HPV register 2013, National HPV Vaccination Program Register, Available from: http://www.hpvregister.org.au/health-professionals〉 [cited 2013].
17. Trogstad L., Ung G., Hagerup-Jenssen M., Cappelen I., Haugen I.L., Feiring B. The Norwegian immunisation register-SYSVAK. Euro Surveil 2012, 17(16). (pii=20147).
18. Grove Krause T., Jakobsen S., Haarh M., Molbak K. The Danish vaccination register. Euro Surveil 2012, 17(17). (pii=20155).
19. Centers for Disease Control and Prevention Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2007, 56(Mar (RR-2)):1-24.
20. Dombkowski K. Electronic health record (EHR) interoperability with MCIR: progress to date 2013, IIS & Public Health: Opportunities, Integration, and Sustainability, Denver, CO. Association AIR (Ed.).
21. Flagg E.W., Datta D.S., Saraiya M., Unger E.R., Peters E., Cole L., et al. Population-based surveillance for cervical cancer precursors in three central cancer registries, United States 2009. Cancer Causes Control 2014, 25(5):571-581.
22. North American Association of Central Cancer Registries. Who is certified. [cited 12/17/2014]; Available from: http://www.naaccr.org/Certification/WhoisCertified.aspx
23. North American Association of Central Cancer Registries. Certification levels. [cited 12/17/2014]; Available from: http://www.naaccr.org/Certification/CertificationLevels.aspx
24. Centers for Disease Control and Prevention Progress in immunization information systems-United States, 2010. MMWR Morb Mortal Wkly Rep 2012, 61(Jun (25)):464-467.
25. Centers for Disease Control and Prevention. Q&A About IIS sentinel sites: how are sentinel sites selected? [cited 11/27/2012]; Available from: http://www.cdc.gov/vaccines/programs/iis/activities/sentinel-sites.html#how
26. Enger K.S., Stokley S. Meningococcal conjugate vaccine uptake, measured by Michigan's immunization registry. J Adolesc Health 2007, 40(5):398-404.
27. Centers for Disease Control and Prevention. Estimated vaccination cov-erage with selected vaccines among adolescents aged 13-17 years, bystate and selected local areas-national immunization Survey-Teen, UnitedStates, 2008. 2009. Available from: http://www2a.cdc.gov/nip/coverage/nisteen/nis_iap.asp?fmt=v&rpt=tab01_iap&qtr=Q1/2008-Q4/2008〉 [cited 2013 12/05/2013].
28. Jacquez G.M., Slotnick M.J., Meliker J.R., AvRuskin G., Copeland G., Nriagu J. Accuracy of commercially available residential histories for epidemiologic studies. Am J Epidemiol 2011, 173(2):236-243.